Inventor · disambiguated record
Scott I. Klein
Also filed as: KLEIN SCOTT I
21 granted patents·3 pending applications·474 citations·filing 1988–2003
95Inventor score
Files withRHONE POULENC RORER PHARMA9AVENTIS PHARM PROD INC5RORER PHARMACEUTICAL CORP5AVENTIS PHARMA INC3
Top patents by PatentIndex Score
24 records- 0193US6323227B1Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amidesAVENTIS PHARM PROD INC·Filed 1999·Granted Nov 27, 2001·76 cites·61 claims
- 0290US6080767ASubstituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amidesAVENTIS PHARM PROD INC·Filed 1997·Granted Jun 27, 2000·100 cites·43 claims
- 0386US4952562AAnti-thrombotic peptides and pseudopeptidesRORER PHARMACEUTICAL CORP·Filed 1989·Granted Aug 28, 1990·57 cites·12 claims
- 0483US5053392ANovel arginine, glycine, aspartic acid derivatives as platelet-aggregation inhibitorsRHONE POULENC RORER PHARMA·Filed 1989·Granted Oct 1, 1991·45 cites·8 claims
- 0581US5086069AAnti-thrombotic peptide and pseudopeptide derivativesRORER PHARMACEUTICAL CORP·Filed 1990·Granted Feb 4, 1992·60 cites·11 claims
- 0678US5064814AAnti-thrombotic peptide and pseudopeptide derivativesRHONE POULENC RORER PHARMA·Filed 1990·Granted Nov 12, 1991·40 cites·7 claims
- 0775US4859683ACertain benzoxepins and their pharmaceutical compositions and methodsRORER PHARMACEUTICAL CORP·Filed 1988·Granted Aug 22, 1989·10 cites·14 claims
- 0875US4857517AQuinuclidyl benzoxepins as 5-HT3 antagonistsRORER PHARMACEUTICAL CORP·Filed 1988·Granted Aug 15, 1989·10 cites·14 claims
- 0973US4924010ABenzoxepins as intermediates to 5HT3 antagonistsRORER PHARMACEUTICAL CORP·Filed 1989·Granted May 8, 1990·9 cites·7 claims
- 1072US5246942APharmaceutically useful dibenzofurancarboxamides of specific stereo-configurationRHONE POULENC RORER PHARMA·Filed 1992·Granted Sep 21, 1993·12 cites·18 claims
- 1164US6140504ASubstituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amidesAVENTIS PHARM PROD INC·Filed 2000·Granted Oct 31, 2000·2 cites·2 claims
- 1264US5332726AAntithrombotic peptides and pseudopeptidesRHONE POULENC RORER PHARMA·Filed 1992·Granted Jul 26, 1994·22 cites·21 claims
- 1356US5258398AAntithrombotic diaminoalkanoic acid derivativesRHONE POULENC RORER PHARMA·Filed 1991·Granted Nov 2, 1993·5 cites·28 claims
- 1453US6797700B2Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptidesAVENTIS PHARMA INC·Filed 2001·Granted Sep 28, 2004·0 cites·2 claims
- 1552US5780590AAntithrombotic azacycloalkylalkanoyl peptides and pseudopeptidesRHONE POULENC RORER PHARMA·Filed 1996·Granted Jul 14, 1998·7 cites·5 claims
- 1649US5051405AAnti-thrombotic peptides and pseudopeptidesRHONE POULENC RORER PHARMA·Filed 1989·Granted Sep 24, 1991·13 cites·7 claims
- 1748US2004067988A1Piperididinyl and N-amidinopiperidinyl derivativesAVENTIS PHARMA INC·Filed 2003·Application pending·0 cites
- 1844US2002016339A1Piperididinyl and N-amidinopiperidinyl derivativesFiled 2001·Application pending·0 cites
- 1943US7361663B2N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor XaAVENTIS PHARMA INC·Filed 2003·Granted Apr 22, 2008·0 cites·20 claims
- 2039US2003092698A1N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor XaFiled 2002·Application pending·0 cites
- 2136US6277865B1Piperididinyl and N-amidinopiperidinyl derivativesAVENTIS PHARM PROD INC·Filed 1999·Granted Aug 21, 2001·3 cites·39 claims
- 2234US5866685AAntithrombotic azacycloalkylalkanoyl peptides and pseudopeptidesRHONE POULENC RORER PHARMA·Filed 1994·Granted Feb 2, 1999·3 cites·35 claims
- 2333US6274705B1Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptidesAVENTIS PHARM PROD INC·Filed 1998·Granted Aug 14, 2001·0 cites·6 claims
- 2430US5328900AAnti-thrombotic peptide and pseudopeptide derivativesRHONE POULENC RORER PHARMA·Filed 1992·Granted Jul 12, 1994·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Scott I. Klein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →